---
title: "BLADE AIR MOBILITY INC C/WTS 07/05/2026 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 54.31 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239881584.md"
datetime: "2025-05-12T15:29:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239881584.md)
  - [en](https://longbridge.com/en/news/239881584.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239881584.md)
---

# BLADE AIR MOBILITY INC C/WTS 07/05/2026 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 54.31 M

Revenue: As of FY2025 Q1, the actual value is USD 54.31 M.

EPS: As of FY2025 Q1, the actual value is USD -0.04.

### Passenger Segment

-   **Revenue**: $18.4 million for the three months ended March 31, 2025, an increase of 18.5% from $15.5 million in 2024.
-   **Adjusted EBITDA**: Improved by $2.7 million from - $2.7 million in 2024 to $0.1 million in 2025, driven by higher revenue and lower cost of revenue as a percentage of revenue in Europe and Jet charter.

### Medical Segment

-   **Revenue**: $35.9 million for the three months ended March 31, 2025, a decrease of 0.2% from $36.0 million in 2024.
-   **Adjusted EBITDA**: Decreased by $0.3 million, or 7.1%, from $4.4 million in 2024 to $4.1 million in 2025, largely due to lower utilization of the owned fleet.

### Consolidated Financial Metrics

-   **Net Loss**: Improved by $0.7 million from - $4.2 million in 2024 to - $3.5 million in 2025.
-   **Adjusted EBITDA**: Improved by $2.3 million from - $3.5 million in 2024 to - $1.2 million in 2025.
-   **Gross Profit**: Increased by $2.2 million from $5.9 million in 2024 to $8.1 million in 2025.
-   **Flight Profit**: Increased by $1.8 million, or 18.1%, from $10.1 million in 2024 to $12.0 million in 2025.

### Future Outlook and Strategy

-   **Core Business Focus**: Blade Air Mobility, Inc. plans to leverage its asset-light model and proprietary technologies to transition to Electric Vertical Aircraft (EVA), aiming for lower cost, quiet, and emission-free air mobility.
-   **Non-Core Business**: The company is focusing on expanding its MediMobility Organ Transport services and enhancing its technology-enabled solutions for organ transport logistics.

### Related Stocks

- [BLDEW.US](https://longbridge.com/en/quote/BLDEW.US.md)
- [SRTAW.US](https://longbridge.com/en/quote/SRTAW.US.md)